Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agios Pharmaceuticals (AGIO) Revenue: 2011-2024

Historic Revenue for Agios Pharmaceuticals (AGIO) over the last 13 years, with Dec 2024 value amounting to $36.5 million.

  • Agios Pharmaceuticals' Revenue rose 43.69% to $12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.8 million, marking a year-over-year increase of 36.26%. This contributed to the annual value of $36.5 million for FY2024, which is 36.07% up from last year.
  • According to the latest figures from FY2024, Agios Pharmaceuticals' Revenue is $36.5 million, which was up 36.07% from $26.8 million recorded in FY2023.
  • Agios Pharmaceuticals' 5-year Revenue high stood at $36.5 million for FY2024, and its period low was $6.6 million during FY2021.
  • Moreover, its 3-year median value for Revenue was $26.8 million (2023), whereas its average is $25.9 million.
  • Data for Agios Pharmaceuticals' Revenue shows a peak YoY spiked of 114.49% (in 2022) over the last 5 years.
  • Agios Pharmaceuticals' Revenue (Yearly) stood at $6.6 million in 2021, then skyrocketed by 114.49% to $14.2 million in 2022, then soared by 88.36% to $26.8 million in 2023, then soared by 36.07% to $36.5 million in 2024.